OT
Ocular Therapeutix Inc
🇩🇪XFRA.0OTGermanyHealthcare
€9.00EURup +0.05 (+0.56%)OpenEnd of day5:04 PM
Price€9.00+0.05 (+0.56%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US67576A1007
- CUSIP
- Not reported
Company
- Employees
- 325
- Headquarters
- Bedford, United States
- Website
- https://www.ocutx.com
- CEO
- Dr. Pravin U. Dugel M.D.
Market
- Shares outstanding
- 213M
- Market cap
- €1.92B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- €1.92B
- EPS LTM
- -$1.34
- P/E LTM
- -7.33
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $52.05M-8.14%down year on year
- Net income
- -$301.45M-39.08%down year on year
- Gross margin
- 87.11%-2.58%down year on year
- Free cash flow
- -$255.1M-42.22%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.